Radioactive Transition Metals for Imaging and Therapy
- 9 October 2018
- journal article
- review article
- Published by American Chemical Society (ACS) in Chemical Reviews
- Vol. 119 (2), 870-901
- https://doi.org/10.1021/acs.chemrev.8b00281
Abstract
Nuclear medicine is composed of two complementary areas, imaging and therapy. Positron emission tomography (PET) and single-photon imaging, including single-photon emission computed tomography (SPECT), comprise the imaging component of nuclear medicine. These areas are distinct in that they exploit different nuclear decay processes and also different imaging technologies. In PET, images are created from the 511 keV photons produced when the positron emitted by a radionuclide encounters an electron and is annihilated. In contrast, in single-photon imaging, images are created from the γ rays (and occasionally X-rays) directly emitted by the nucleus. Therapeutic nuclear medicine uses particulate radiation such as Auger or conversion electrons or β– or α particles. All three of these technologies are linked by the requirement that the radionuclide must be attached to a suitable vector that can deliver it to its target. It is imperative that the radionuclide remain attached to the vector before it is delivered to its target as well as after it reaches its target or else the resulting image (or therapeutic outcome) will not reflect the biological process of interest. Radiochemistry is at the core of this process, and radiometals offer radiopharmaceutical chemists a tremendous range of options with which to accomplish these goals. They also offer a wide range of options in terms of radionuclide half-lives and emission properties, providing the ability to carefully match the decay properties with the desired outcome. This Review provides an overview of some of the ways this can be accomplished as well as several historical examples of some of the limitations of earlier metalloradiopharmaceuticals and the ways that new technologies, primarily related to radionuclide production, have provided solutions to these problems.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (5R01HL108107, R00HL125728-03, U01HL127522 ? 18150031)
- Stony Brook University
- Children?s Hospital Radiology Foundation
This publication has 202 references indexed in Scilit:
- Computational Predictions of Volatile Anesthetic Interactions with the Microtubule Cytoskeleton: Implications for Side Effects of General AnesthesiaPLOS ONE, 2012
- Sodium Iodide Symporter for Nuclear Molecular Imaging and Gene Therapy: From Bedside to Bench and BackTheranostics, 2012
- Synthesis, Cu(ii) complexation,64Cu-labeling and biological evaluation of cross-bridged cyclam chelators with phosphonate pendant armsDalton Transactions, 2011
- Imaging cancer using PET — the effect of the bifunctional chelator on the biodistribution of a 64Cu-labeled antibodyNuclear Medicine and Biology, 2011
- The complexation of rhodium(iii) with acyclic diaminedithioether (DADTE) ligandsDalton Transactions, 2010
- Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of DiseaseChemical Reviews, 2010
- Structure, Properties, and Engineering of the Major Zinc Binding Site on Human AlbuminJournal of Biological Chemistry, 2009
- Gd−Hydroxypyridinone (HOPO)-Based High-Relaxivity Magnetic Resonance Imaging (MRI) Contrast AgentsAccounts of Chemical Research, 2009
- [ 64 Cu-NOTA-8-Aoc-BBN(7-14)NH 2 ] targeting vector for positron-emission tomography imaging of gastrin-releasing peptide receptor-expressing tissuesProceedings of the National Academy of Sciences of the United States of America, 2007
- Preparation of Re(I)− and 99mTc(I)−Metallocarboranes in Water under Weakly Basic Reaction ConditionsInorganic Chemistry, 2004